BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26264809)

  • 1. Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model.
    Pessina A; Leonetti C; Artuso S; Benetti A; Dessy E; Pascucci L; Passeri D; Orlandi A; Berenzi A; Bonomi A; Coccè V; Ceserani V; Ferri A; Dossena M; Mazzuca P; Ciusani E; Ceccarelli P; Caruso A; Portolani N; Sisto F; Parati E; Alessandri G
    J Exp Clin Cancer Res; 2015 Aug; 34(1):82. PubMed ID: 26264809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phyto-sesquiterpene lactone deoxyelephantopin and cisplatin synergistically suppress lung metastasis of B16 melanoma in mice with reduced nephrotoxicity.
    Chao WW; Cheng YW; Chen YR; Lee SH; Chiou CY; Shyur LF
    Phytomedicine; 2019 Mar; 56():194-206. PubMed ID: 30668340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
    Amarzguioui M; Peng Q; Wiiger MT; Vasovic V; Babaie E; Holen T; Nesland JM; Prydz H
    Clin Cancer Res; 2006 Jul; 12(13):4055-61. PubMed ID: 16818705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syngeneic murine metastasis models: B16 melanoma.
    Giavazzi R; Decio A
    Methods Mol Biol; 2014; 1070():131-40. PubMed ID: 24092437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
    Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
    Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of mesenchymal stem cells on metastasis development in mice in vivo.
    Meleshina AV; Cherkasova EI; Shirmanova MV; Klementieva NV; Kiseleva EV; Snopova LВ; Prodanets NN; Zagaynova EV
    Stem Cell Res Ther; 2015 Feb; 6(1):15. PubMed ID: 25888992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models.
    De Flora S; D'Agostini F; Masiello L; Giunciuglio D; Albini A
    Int J Cancer; 1996 Sep; 67(6):842-8. PubMed ID: 8824557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    Humphries MJ; Yamada KM; Olden K
    J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
    Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
    Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
    Zheng HQ; Liu DY
    Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.
    Timmons JJ; Cohessy S; Wong ET
    J Vis Exp; 2016 May; (111):. PubMed ID: 27285567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells.
    Hyoudou K; Nishikawa M; Umeyama Y; Kobayashi Y; Yamashita F; Hashida M
    Clin Cancer Res; 2004 Nov; 10(22):7685-91. PubMed ID: 15570002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma.
    Liu X; Chan SY; Ho PC
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):167-74. PubMed ID: 18465132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
    Jeanne A; Boulagnon-Rombi C; Devy J; Théret L; Fichel C; Bouland N; Diebold MD; Martiny L; Schneider C; Dedieu S
    Clin Exp Metastasis; 2016 Oct; 33(7):637-49. PubMed ID: 27349907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of ginsenoside-Rg3 on lung metastasis of mouse melanoma transfected with ribonuclease inhibitor].
    Liu JW; Chen JX; Yu LH; Tian YX; Cui XY; Yan Q; Fu L
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):722-5. PubMed ID: 15733388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The molecular mechanism of extravasation in mouse melanoma lung metastasis model].
    Pang LM; Zhao CJ; Zhao YW; Li ZM; Yang HS; Wei YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):594-8. PubMed ID: 22007479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitable indices for evaluating the intensity of tumor metastasis in a mouse experimental metastatic model.
    Yoshikawa N; Nakamura K; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    In Vivo; 2001; 15(6):485-8. PubMed ID: 11887333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.
    Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF
    Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.